Cargando…
PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081901/ http://dx.doi.org/10.1186/2045-7022-4-S1-P39 |
| _version_ | 1782324174666072064 |
|---|---|
| author | Valle, Marta Estevez, Javier Martial, Lisa Charlotte Santamaria, Eva Izquierdo, Iñaki |
| author_facet | Valle, Marta Estevez, Javier Martial, Lisa Charlotte Santamaria, Eva Izquierdo, Iñaki |
| author_sort | Valle, Marta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4081901 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40819012014-07-18 PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children Valle, Marta Estevez, Javier Martial, Lisa Charlotte Santamaria, Eva Izquierdo, Iñaki Clin Transl Allergy Poster Discussion Presentation BioMed Central 2014-02-28 /pmc/articles/PMC4081901/ http://dx.doi.org/10.1186/2045-7022-4-S1-P39 Text en Copyright © 2014 Valle et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Discussion Presentation Valle, Marta Estevez, Javier Martial, Lisa Charlotte Santamaria, Eva Izquierdo, Iñaki PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children |
| title | PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children |
| title_full | PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children |
| title_fullStr | PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children |
| title_full_unstemmed | PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children |
| title_short | PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children |
| title_sort | pd39 - application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children |
| topic | Poster Discussion Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081901/ http://dx.doi.org/10.1186/2045-7022-4-S1-P39 |
| work_keys_str_mv | AT vallemarta pd39applicationofpopulationpharmacokineticmodelingandsimulationinthedesignoftheoptimaldoseregimeofrupatadineinchildren25yearoldchildren AT estevezjavier pd39applicationofpopulationpharmacokineticmodelingandsimulationinthedesignoftheoptimaldoseregimeofrupatadineinchildren25yearoldchildren AT martiallisacharlotte pd39applicationofpopulationpharmacokineticmodelingandsimulationinthedesignoftheoptimaldoseregimeofrupatadineinchildren25yearoldchildren AT santamariaeva pd39applicationofpopulationpharmacokineticmodelingandsimulationinthedesignoftheoptimaldoseregimeofrupatadineinchildren25yearoldchildren AT izquierdoinaki pd39applicationofpopulationpharmacokineticmodelingandsimulationinthedesignoftheoptimaldoseregimeofrupatadineinchildren25yearoldchildren |